Prenatal exposure to dichlorodiphenyldichloroethylene (DDE) is associated with decreased motor development during the first year of life, though the effects of DDE in the neonatal stage are not conclusive. The main aim of this study was to evaluate the association between prenatal DDE exposure and neonatal neurodevelopment in a cohort from four municipalities in the state of Morelos, Mexico. The children (265), born from pregnancies with no perinatal complications, were evaluated at 1 month of age (±7 days) for the presence of abnormal reflexes with the Brazelton Scale (NBAS), neurological soft signs with the Graham-Rosenblith Scale, as well as mental and psychomotor development by the Bayley Scales of Infant Development. Maternal DDE concentrations during each trimester of the pregnancy were determined by gas chromatography. Multiple linear and ordinal logistic models assessed the association between DDE and the outcomes of interest. Prenatal exposure to DDE was associated with a non-significant increase in neurological soft signs (6-8%) and a decrease in psychomotor (b 1T ¼ À0.02) and mental (b 2T ¼ À0.03 and b 3T ¼ À0.19) development. Our results are consistent with previous studies and suggest that prenatal DDE exposure is not associated with neurological functions present in the neonatal stage.
Introduction
Dichlorodiphenyldichloroethylene (DDE), the main metabolite of DDT, has been consistently associated with a decrease in psychomotor development, measured with the Bayley Scales of Infant Development during the first year of life (Ribas-Fito´et al., 2003; Eskenazi et al., 2006; TorresSa´nchez et al., 2007) . However, the age at which the damage begins to manifest itself has not yet been determined.
Five epidemiological studies performed in the US have evaluated the effect of DDE on neonatal neurodevelopment using the Brazelton Scale (NBAS), with inconclusive results. Three of them with median ranged from 0.10 to B8 parts per billion (p.p.b.) wet basis DDE concentrations (Stewart et al., 2000; Engel et al., 2007; Fenster et al., 2007) found no association between prenatal DDE exposure and neonatal neurodevelopment. In contrast, Rogan et al. (1986) , with the largest sized sample and median maternal DDE exposure of 12.6 p.p.b., reported a significant association between prenatal DDE exposure and hyporeflexia, while Sagiv et al. (2008) observed irritability and decreased attention at 2 weeks of age with lower (0.48 p.p.b.) cord blood DDE levels. These two positive studies differ from those with negative results, mainly in the evaluation of exposure through a mixture of milk, blood, cord and placental DDE levels (Rogan et al., 1986) or in the way in which attention was measured (Sagiv et al., 2008) . Another possible explanation for the lack of agreement may be a limited sensitivity of the NBAS to detect damage at this age.
The objective of this study was to evaluate the association between prenatal exposure to DDE and neonatal neurodevelopment, measured through the reflex component of the NBAS, the neurological soft signs of the GrahamRosenblith Scale and mental development index (MDI) and psychomotor development index (PDI) of the Bayley Scales of Infant Development.
Methods
From January 2001 to June 2009, we performed a cohort study in four municipalities of the state of Morelos, Mexico where DDT was used until 1998 due to endemic malaria.
One objective of the cohort was to evaluate child neurodevelopment. Women of reproductive age, who intended getting pregnant in the near future and who had no history of chronic diseases nor past or present anti-convulsive treatments were identified during premarital counseling required by law. These women were monitored before and after their pregnancy and were interviewed to determine their sociodemographic characteristics, reproductive history, dietary habits and the evolution of pregnancy. In addition, we made anthropometric measurements and collected a blood sample during each trimester of their pregnancy to determine DDE. Detailed information of cohort assembling procedures is published elsewhere (Torres-Sa´nchez et al., 2007) .
After the birth, babies participated in the evaluation of neurodevelopment at 1 month ± 7 days. The children's anthropometric measurements were taken (weight, height and cephalic perimeter). We used a structured questionnaire to obtain information on birth conditions, weight, height, cephalic circumference, as well as the initiation and duration of breastfeeding.
Study Population
Of the 442 births recorded during the study period, 17 children were excluded due to one of the following conditions: twin pregnancy, severe cerebral atrophy, extreme prematurity, neonatal death, hypothyroidism, and cleft lip and palate; 21 more children were excluded for weighing o2000 g or because of a diagnosis of perinatal asphyxia. In addition, 38 deserted during the first month, 68 had no neurodevelopmental evaluation and 33 had no maternal DDE measurements. Causes of desertion were change of address and parents' lack of interest in continuing with the study. The final study population comprised 265 children who were born after simple pregnancies, without perinatal complications, with a birthweight of 42000 g, who had a neonatal evaluation and with maternal concentrations of DDE.
Once each participant was informed of the objectives of the present study, she signed an informed consent letter, and after the birth a new consent was obtained to evaluate the children. This study was approved by the Ethics and Research Committee of the National Institute of Public Health.
Evaluation of Prenatal DDE Exposure
In each trimester of the pregnancy, each participant was requested to provide a blood sample (7 ml), which was centrifuged and the serum that was obtained was stored at À701C, in glass vials with a teflon cap (prewashed with hexane, pesticide grade), until the moment of analysis. The protocol was the one recommended by the US EPA (1980) . Serum DDE levels were determined by gas chromatography with an electron capture detector (3400 model; Varian, Palo Alto, CA, USA) and were expressed in wet basis as nanograms per milliliter (p.p.b.). Detection limits were 0.05 and 0.0045 ng/ml for DDE and p,p'-DDT, respectively.
Quality control consisted of fortification of each serum sample with Aldrin and the percentage of recovery was 98.15 ± 8.8%. For each 10 sample lot, a sample of bovine serum was analyzed with known quantities of b-hexachlorocyclohexane (b-HCH), aldrin, hexachlorobencene (HCB), DDE and 1,1-dichloro-2,2-bis (p-chlorophenyl) ethane (p,p'-DDD) and a randomly selected sample was analyzed in duplicate, with a mean variation coefficient for DDE of 4.37%. As part of external quality control, independent analysis of 4% of the samples by our laboratory and the laboratory of the division of Occupational and Environmental Medicine at the Mount Sinai School of Medicine in NY resulted in a Bland-Altman correlation coefficient of 0.98.
Evaluation of Neurodevelopment
The neurological soft signs of the Graham-Rosenblith Scale (Rosenblith, 1979) , and the complete Bayley Scales of Infant Development were used in this study because both share items with the NBAS. Bayley Scales of Infant Development are considered a gold standard for neurodevelopment evaluation. All tests were applied at the participant's home, in the presence of the mother and in the room with the least external disturbance. Two psychologists with experience in conducting and interpreting these tests and who were blinded to the condition of prenatal exposure to DDE performed the evaluations.
Brazelton Neonatal Behavioral Assessment Scale The NBAS (Brazelton and Nugent, 1995) has two components: behavioral and reflex. For this study, only the reflex scale was considered (a total of 18) among which the following are included: plantar, palmar (hand grasp), ankle clonus, Babinski, standing, walking, placing, incurvation, crawling, Glabella, tonic deviationFhead and eyes, nystagmus, tonic-neck reflex, Moro, rooting, sucking, passive resistance in legs and arms. The score of each reflex ranged from 0 to 4 and the final score was the sum of the reflexes that are considered to be abnormal and which are present in the newborn. A value of zero is the absence of these reflexes.
Graham-Rosenblith Scale Only the Neurological Soft
Signs component of the Graham-Rosenblith Scale was used. These are a total of six signs: abnormal crying, shaking, visual abnormalities, marked changes in states, hypersensitivity and tremors. The presence of one or more of these signs indicates poor performance; the absence of signs shows normal and adequate performance of children. The final score reports the total abnormal neurological soft signs that were present. (Bayley, 1993) was designed to evaluate children who are between 1 and 42 months old and it includes two indexes, the MDI and the PDI. The standard average for each one is 100 ± 15 (1 SD) points. This study used the version translated into Spanish previously used in Mexico (Gomaa et al., 2002; Hu et al., 2006; Torres-Sa´nchez et al., 2007) . We evaluated interexaminer reliability by calculating the correlation in MDI and PDI scores between the testing and observing psychologists with 10 subjects. The interobserver agreement of the evaluators was 0.96 for the MDI and 0.98 for the PDI.
Bayley Scales of Infant Development This test
Each mother took the Wechsler Intelligence Test for adults to obtain her intellectual coefficient (IQ; Wechsler, 1981) .
Statistical Analysis
The descriptive analysis included a comparison of children included in the analysis and those who were not included, according to maternal and child variables. The w 2 -test and Student's t-test were used for categorical and continuous variables, respectively. Abnormal reflexes and NSS were categorized as absence, presence of one and two, or more. The distribution of maternal concentrations of DDE was skewed to the right, and was log-transformed before analysis. The geometric mean and standard deviation of DDE concentration were estimated by reflex category and neurological soft signs.
The association between prenatal exposure to DDE in each trimester of the pregnancy and abnormal reflexes or NSS was estimated using ordinal logistic regression models, where the reference category was the absence of the characteristic under study. The Brant test (Brant, 1990 ) evaluated if the model satisfied the proportional odds assumption. Linear regression models estimated the association of DDE with PDI and MDI. To facilitate interpretation of the results, all DDE coefficients in the models were transformed to log base 2 DDE by multiplying 0.69 and expressed as change observed by doubling the DDE concentration.
Known risk factors for neurodevelopment were evaluated as potential confounders. Only those variables that modified the coefficient by 410% remained in the model. All analyses were done using the Stata 10 statistical package (Stata, College Station, TX, USA).
Results
We detected no significant differences between the children who were included and those who were not included in the analysis (Table 1) . Geometric means of DDE in maternal serum during pregnancy varied between 6.33 and 7.27 ng/ml for the first and third trimesters, respectively. The observed increase between both trimesters was not statistically significant.
The number of abnormal reflexes and neurological soft signs fluctuated between 0 and 4. The percentage of children with two or more abnormal reflexes and with two or more neurological soft signs was 16.6% and 3.81%, respectively. On average, the children's mental development (MDI ¼ 98.5 ± 4.5; P 10À90 ¼ 94-104) and psychomotor development (PDI ¼ 97.6 ± 7.1; P 10À90 ¼ 88-107) were within normal ranges.
The proportion of two or more abnormal reflexes was significantly greater among boys than among girls. On the other hand, the presence of neurological soft signs was not associated with any maternal or child characteristics. There were no significant differences in maternal concentrations of DDE according to the presence or absence of abnormal reflexes or neurological soft signs (Table 2) . A better PDI performance was observed among children of older mothers, born from a first pregnancy by cesarean section and with greater weight at birth. On the other hand, the variables that had an influence on better MDI performance were maternal age, education, and IQ, besides a greater weight at birth and greater gestational age. Doubling the DDE concentration in the first trimester of pregnancy was associated with a reduction of À0.03 points in the PDI, while a similar increase in the second and third trimesters of pregnancy was associated with a reduction of À0.04 and À0.18 in the MDI, respectively. None of these associations was statistically significant (Table 3) .
After adjusting for maternal age and occupation, birth weight and sex of the newborn, doubling the DDE concentration in any of the trimesters of pregnancy was not associated with an increased risk of having a greater number of abnormal reflexes. In contrast, an equal change in DDE concentration in the first and second trimesters of pregnancy Gestational age (week) Mean ± SD 39.2 ± 1.4 39.3 ± 1.5 39.4 ± 1.2 39.3 ± 1.5 39.2 ± 1.3 38.9 ± 1.4
Prenatal DDE levels (ng/ml) e was associated with a non-significant increase of 6% and 8% in the odds of having more neurological soft signs. The changes observed in PDI and MDI were not modified after adjusting for breastfeeding, maternal age, schooling, parity, birthweight, sex of the newborn and maternal IQ (Table 4) .
Discussion
The results of this study suggest that prenatal exposure to DDE is not associated with a measurable damage in neurological functions present during the first month of age and are consistent with those of previous studies (Stewart et al., 2000; Engel et al., 2007; Fenster et al., 2007) that evaluated the same association, using only the Brazelton Scale. However, it cannot be ruled out that latent neurodevelopment impairment emerges at later ages as has been found in other studies (Ribas-Fito´et al., 2003 Eskenazi et al., 2006; Torres-Sa´nchez et al., 2007) . Some methodological considerations must be taken into account when interpreting these results. Low sensitivity in neurodevelopment measures might have reduced the ability to detect an association with DDE. Previous studies have measured neurodevelopment only with the Brazelton Scale; as far as we know, this is the first study that evaluated early DDE interference in development using the neurological soft signs component of the Graham-Rosenblith Scale and the Bayley Scales of Infant Development and none of the tests reveals significant results. The tests were applied by trained and blinded personnel, thus strengthening the negative results; however, lack of overall power due to small sample size should not be ruled out.
It is unlikely that these findings are a consequence of a selection bias, as there were no significant differences between children who were included and not included in the analysis, regarding to selected maternal and infant characteristics. The possibility of confounding as an alternative explanation for the obtained results is unlikely, because known potential confounders such as birthweight, type of birth and other known determinants of neurodevelopment, were considered in the analysis.
Another possible explanation would be that the DDE concentrations observed in this population could be different to those in prior studies. In this sense, the observed DDE concentrations in this study are similar to those of the negative study of Fenster et al. (2007) , and are greater than those reported by Sagiv et al. (2008) , where, besides DDE, that sample also had a prior event of contamination by polychlorinated biphenyls.
Two prior studies disagree on the findings; however, they are not comparable to ours. Rogan et al. (1986) reported that a greater exposure to DDE, estimated through the combination of concentrations observed in the umbilical cord, maternal serum, placenta and milk at birth, was associated with a significantly greater proportion of children with hyporeflexia before 3 weeks of age. No information on the validity of this method (that differs to ours), for measuring exposure, was reported by the authors. Another study reported that DDE in umbilical cord was associated with a deficiency in neonatal development (Sagiv et al., 2008) , focused mainly on the components of the Brazelton test which evaluates the attention span or abilities potentially associated with this capability. The way in which attention measured was generating a variable based on the ability to reach a maximum state of alert in the child during the evaluation; and thus, its results are not comparable to any of ours.
Summarizing, the results of this study do not show any association between prenatal DDE exposure and neurodevelopment damage at 1 month of age, measured by reflexes component of Brazelton Scale, neurological soft signs of Graham-Rosenblith and the Bayley Scales of Infant Development.
